• LINTUZUMAB chembl:CHEMBL2109150 Antineoplastic

    Alternate Names:

    HUM-195
    LINTUZUMAB
    SGN-33
    HUM195
    HUMA-195-GELONIN
    ZAMYL

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Score: 20.61

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:
    Trial Name lintuzumab, SGN-33
    Novel drug target Established target
    Mechanism of Interaction Myeloid cell surface antigen CD33 other

    PMIDs:
    None found